Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Bulletin of Experimental Biology and Medicine|March 11, 2026
Spontaneous Carcinoogenesis: Regulation of Adhesion Disorders and Cancer PreventionE V Bocharov, R V Karpova, V G Kucheryanu, et al.
Klinicheskaia Laboratornaia Diagnostika|May 28, 2020
[The content of the soluble forms PD-1 and PD-L1 in blood serum of patients with gastric cancer and their relationship with clinical and morphological characteristics of the disease.]E S Gershtein, N A Ognerubov, V L Chang, et al.
Molekuliarnaia Biologiia|March 28, 2023
[Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer]A M Danishevich, N I Pospehova, A M Stroganova, et al.
Bulletin of Experimental Biology and Medicine|June 4, 2020
A Group of miRNA as Candidates for Prognostic Biomarkers of Gastric Cancer MetastasisF M Kipkeeva, Т А Muzaffarova, M P Nikulin, et al.
Khirurgiia|August 7, 2021
[Surgical and combined treatment of patients with duodenal stromal tumors]P P Arkhiri, I S Stilidi, S N Nered, et al.
Bulletin of Experimental Biology and Medicine|July 19, 2022
Blood Serum Zonulin in Colorectal Cancer, Autoimmune Bowel Diseases, and Irritable Bowel SyndromeN E Kushlinskii, E S Gershtein, N N Zybina, et al.
Bulletin of Experimental Biology and Medicine|December 12, 2023
Soluble B7-H3 in Colorectal CancerO V Kovaleva, A N Gratchev, N Yu Sokolov, et al.
Klinicheskaia Laboratornaia Diagnostika|April 1, 2021
Prognostic significance of soluble forms of immune checkpoint PD-1/PDL1 receptor and ligand in blood plasma of gastric cancer patientsNikolay Evgenievich Kushlinskii, E S Gershtein, V L Chang, et al.
Free Radical Biology & Medicine|May 24, 2026
Multi-Omics Profiling of Oxylipins and Gene Expression in Pediatric Sarcomas Identifies Metastatic Signatures and Prognostic ModelsD V Chistyakov, A I Nikolskaya, V O Gorbatenko, et al.
Biomeditsinskaia Khimiia|June 18, 2021
[Possibilities of in silico estimations for the development of pharmaceutical composition phytoladaptogene cytotoxic for bladder cancer cells]N S Ionov, M A Baryshnikova, E V Bocharov, et al.
Pageof 6